New developments in the pathogenesis of obesity-induced hypertension

Vasilios Kotsis, Peter Nilsson, Guido Grassi, Giuseppe Mancia, Josep Redon, Frank Luft, Roland Schmieder, Stefan Engeli, Stella Stabouli, Christina Antza, Denes Pall, Markus Schlaich, Jens Jordan

Research output: Contribution to journalArticle

Abstract

Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential genetic and racial differences or environmental factors that may protect obese patients against the development of hypertension and other co-morbidities. Specific mutations in the leptin and the melaninocortin receptor genes in animal models of obesity without hypertension, the actions of α-melanocyte stimulating hormone, and SNS activity in obesity-related hypertension may promote recognition of protective and promoting factors for hypertension in obesity. Furthermore, gene-environment interactions may have the potential to modify gene expression and epigenetic mechanisms could also contribute to the heritability of obesity-induced hypertension. Finally, differences in nutrition, gut microbiota, exposure to sun light and exercise may play an important role in the presence or absence of hypertension in obesity.

Original languageEnglish
Pages (from-to)1499-1508
Number of pages10
JournalJournal of Hypertension
Volume33
Issue number8
DOIs
Publication statusPublished - Aug 11 2015

Fingerprint

Obesity
Hypertension
Melanocyte-Stimulating Hormones
Leptin Receptors
Gene-Environment Interaction
Social Environment
Solar System
Chronic Renal Insufficiency
Epigenomics
Type 2 Diabetes Mellitus
Lung Diseases
Cardiovascular Diseases
Animal Models
Genotype
Exercise
Morbidity
Gene Expression
Light
Mutation
Genes

Keywords

  • a-MSH
  • gut microbiota
  • hypertension
  • leptin
  • obesity
  • potassium
  • salt
  • sun light
  • sympathetic nervous system

ASJC Scopus subject areas

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Kotsis, V., Nilsson, P., Grassi, G., Mancia, G., Redon, J., Luft, F., ... Jordan, J. (2015). New developments in the pathogenesis of obesity-induced hypertension. Journal of Hypertension, 33(8), 1499-1508. https://doi.org/10.1097/HJH.0000000000000645

New developments in the pathogenesis of obesity-induced hypertension. / Kotsis, Vasilios; Nilsson, Peter; Grassi, Guido; Mancia, Giuseppe; Redon, Josep; Luft, Frank; Schmieder, Roland; Engeli, Stefan; Stabouli, Stella; Antza, Christina; Pall, Denes; Schlaich, Markus; Jordan, Jens.

In: Journal of Hypertension, Vol. 33, No. 8, 11.08.2015, p. 1499-1508.

Research output: Contribution to journalArticle

Kotsis, V, Nilsson, P, Grassi, G, Mancia, G, Redon, J, Luft, F, Schmieder, R, Engeli, S, Stabouli, S, Antza, C, Pall, D, Schlaich, M & Jordan, J 2015, 'New developments in the pathogenesis of obesity-induced hypertension', Journal of Hypertension, vol. 33, no. 8, pp. 1499-1508. https://doi.org/10.1097/HJH.0000000000000645
Kotsis, Vasilios ; Nilsson, Peter ; Grassi, Guido ; Mancia, Giuseppe ; Redon, Josep ; Luft, Frank ; Schmieder, Roland ; Engeli, Stefan ; Stabouli, Stella ; Antza, Christina ; Pall, Denes ; Schlaich, Markus ; Jordan, Jens. / New developments in the pathogenesis of obesity-induced hypertension. In: Journal of Hypertension. 2015 ; Vol. 33, No. 8. pp. 1499-1508.
@article{3150752178124dd28ac5a15d11a8ac6b,
title = "New developments in the pathogenesis of obesity-induced hypertension",
abstract = "Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential genetic and racial differences or environmental factors that may protect obese patients against the development of hypertension and other co-morbidities. Specific mutations in the leptin and the melaninocortin receptor genes in animal models of obesity without hypertension, the actions of α-melanocyte stimulating hormone, and SNS activity in obesity-related hypertension may promote recognition of protective and promoting factors for hypertension in obesity. Furthermore, gene-environment interactions may have the potential to modify gene expression and epigenetic mechanisms could also contribute to the heritability of obesity-induced hypertension. Finally, differences in nutrition, gut microbiota, exposure to sun light and exercise may play an important role in the presence or absence of hypertension in obesity.",
keywords = "a-MSH, gut microbiota, hypertension, leptin, obesity, potassium, salt, sun light, sympathetic nervous system",
author = "Vasilios Kotsis and Peter Nilsson and Guido Grassi and Giuseppe Mancia and Josep Redon and Frank Luft and Roland Schmieder and Stefan Engeli and Stella Stabouli and Christina Antza and Denes Pall and Markus Schlaich and Jens Jordan",
year = "2015",
month = "8",
day = "11",
doi = "10.1097/HJH.0000000000000645",
language = "English",
volume = "33",
pages = "1499--1508",
journal = "Journal of Hypertension",
issn = "0263-6352",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - New developments in the pathogenesis of obesity-induced hypertension

AU - Kotsis, Vasilios

AU - Nilsson, Peter

AU - Grassi, Guido

AU - Mancia, Giuseppe

AU - Redon, Josep

AU - Luft, Frank

AU - Schmieder, Roland

AU - Engeli, Stefan

AU - Stabouli, Stella

AU - Antza, Christina

AU - Pall, Denes

AU - Schlaich, Markus

AU - Jordan, Jens

PY - 2015/8/11

Y1 - 2015/8/11

N2 - Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential genetic and racial differences or environmental factors that may protect obese patients against the development of hypertension and other co-morbidities. Specific mutations in the leptin and the melaninocortin receptor genes in animal models of obesity without hypertension, the actions of α-melanocyte stimulating hormone, and SNS activity in obesity-related hypertension may promote recognition of protective and promoting factors for hypertension in obesity. Furthermore, gene-environment interactions may have the potential to modify gene expression and epigenetic mechanisms could also contribute to the heritability of obesity-induced hypertension. Finally, differences in nutrition, gut microbiota, exposure to sun light and exercise may play an important role in the presence or absence of hypertension in obesity.

AB - Obesity is a disorder that develops from the interaction between genotype and environment involving social, behavioral, cultural, and physiological factors. Obesity increases the risk for type 2 diabetes mellitus, hypertension, cardiovascular disease, cancer, musculoskeletal disorders, chronic kidney and pulmonary disease. Although obesity is clearly associated with an increased prevalence of hypertension, many obese individuals may not develop hypertension. Protecting factors may exist and it is important to understand why obesity is not always related to hypertension. The aim of this review is to highlight the knowledge gap for the association between obesity, hypertension, and potential genetic and racial differences or environmental factors that may protect obese patients against the development of hypertension and other co-morbidities. Specific mutations in the leptin and the melaninocortin receptor genes in animal models of obesity without hypertension, the actions of α-melanocyte stimulating hormone, and SNS activity in obesity-related hypertension may promote recognition of protective and promoting factors for hypertension in obesity. Furthermore, gene-environment interactions may have the potential to modify gene expression and epigenetic mechanisms could also contribute to the heritability of obesity-induced hypertension. Finally, differences in nutrition, gut microbiota, exposure to sun light and exercise may play an important role in the presence or absence of hypertension in obesity.

KW - a-MSH

KW - gut microbiota

KW - hypertension

KW - leptin

KW - obesity

KW - potassium

KW - salt

KW - sun light

KW - sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=84941209260&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941209260&partnerID=8YFLogxK

U2 - 10.1097/HJH.0000000000000645

DO - 10.1097/HJH.0000000000000645

M3 - Article

C2 - 26103132

AN - SCOPUS:84941209260

VL - 33

SP - 1499

EP - 1508

JO - Journal of Hypertension

JF - Journal of Hypertension

SN - 0263-6352

IS - 8

ER -